Reply to S. Boutayeb et al

Affiliations

¹ Emil Lou, MD, PhD, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; Muhammad Shaalan Beg, MD, University of Texas Southwestern Medical Center, Dallas, TX; Emily Bergsland, MD, University of California San Francisco, San Francisco, CA; Cathy Eng, MD, Vanderbilt-Ingram Cancer Center, Nashville, TN; Alok A. Khorana, MD, Cleveland Clinic, Cleveland, OH; Scott Kopetz, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Sam Lubner, MD, University of Wisconsin, Madison, WI; Leonard Saltz, MD, Memorial Sloan Kettering Cancer Center, New York, NY; Veena Shankaran, MD, MS, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA; and S. Yousuf Zafar, MD, MHS, Duke Cancer Institute, Durham, NC.

Comment

Emil Lou et al. JCO Oncol Pract. 2020 Aug.

. 2020 Aug;16(8):525.

doi: 10.1200/OP.20.00394. Epub 2020 Jun 23.

¹ Emil Lou, MD, PhD, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; Muhammad Shaalan Beg, MD, University of Texas Southwestern Medical Center, Dallas, TX; Emily Bergsland, MD, University of California San Francisco, San Francisco, CA; Cathy Eng, MD, Vanderbilt-Ingram Cancer Center, Nashville, TN; Alok A. Khorana, MD, Cleveland Clinic, Cleveland, OH; Scott Kopetz, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Sam Lubner, MD, University of Wisconsin, Madison, WI; Leonard Saltz, MD, Memorial Sloan Kettering Cancer Center, New York, NY; Veena Shankaran, MD, MS, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA; and S. Yousuf Zafar, MD, MHS, Duke Cancer Institute, Durham, NC.

No abstract available

Comment on

Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
Lou E, Beg S, Bergsland E, Eng C, Khorana A, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY. Lou E, et al. JCO Oncol Pract. 2020 Jul;16(7):383-388. doi: 10.1200/OP.20.00239. Epub 2020 Apr 30. JCO Oncol Pract. 2020. PMID: 32352884 No abstract available.
BRAF-Mutated Metastatic Colon Cancers During COVID-19 Pandemic.
Boutayeb S, El Ghissassi I, Souadka A, Mrabti H, Errihani H. Boutayeb S, et al. JCO Oncol Pract. 2020 Aug;16(8):525. doi: 10.1200/OP.20.00356. Epub 2020 Jun 23. JCO Oncol Pract. 2020. PMID: 32574135 No abstract available.